Visual Outcomes Associated With Patterns of ME Resolution in CRVO Treated With Anti-VEGF,JAMA Ophthalmology

当前位置： X-MOL 学术 › JAMA Ophthalmol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Visual Outcomes Associated With Patterns of ME Resolution in CRVO Treated With Anti-VEGF
JAMA Ophthalmology ( IF 8.1 ) Pub Date : 2022-02-01 , DOI: 10.1001/jamaophthalmol.2021.5619
Sarega Gurudas ₁ , Namritha Patrao ₂ , Luke Nicholson _{1,

2} , Piyali Sen _{1,

2} , Jayashree Ramu ₂ , Sobha Sivaprasad _{1,

2} , Philip Hykin _{1,

2}

Affiliation

This post hoc analysis of the LEAVO Trial assesses best-corrected visual acuity outcomes at 100 weeks based on macular fluid resolution patterns by 52 and 100 weeks among patients receiving anti–vascular endothelial growth factor therapy for central retinal vein occlusion–related macular edema.

中文翻译：